Nabriva Therapeutics plc·4

Jun 25, 9:47 AM ET

Schranz Jennifer 4

4 · Nabriva Therapeutics plc · Filed Jun 25, 2018

Insider Transaction Report

Form 4
Period: 2018-06-22
Schranz Jennifer
Chief Medical Officer
Transactions
  • Purchase

    Ordinary Shares

    2018-06-22$3.73/sh+5,500$20,5155,500 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4